Key result
MMP-2 emerges as a key remodeling protease and potential diagnostic and prognostic biomarker in HF.
Why the study?
Heart failure is a major healthcare challenge, and researching new biological markers like MMP-2 may improve early detection and therapeutic selection.
Does MMP-2 serve as a diagnostic and prognostic marker in patients with heart failure?
Does MMP-2 serve as a diagnostic and prognostic marker in patients with heart failure?
MMP-2 is a promising diagnostic and prognostic biomarker for heart failure, reflecting its role in ventricular remodeling.
No takes yet. Share an insight, caveat, or question.
May aid early HF detection via MMPs; leaves open their role in therapeutic selection pending confirmatory studies.
Alieva et al. (2026) conducted a review in Heart failure. Matrix metalloproteinase 2 (MMP-2) was evaluated. Matrix metalloproteinase 2 (MMP-2) is a key protease involved in heart remodeling and serves as a potential diagnostic and prognostic biomarker in patients with heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: